Biallelic MED27 variants lead to variable ponto-cerebello-lental degeneration with movement disorders.
Female
Humans
Infant
Child, Preschool
Child
Adolescent
Young Adult
Adult
Middle Aged
Epilepsy
/ genetics
Cerebellum
/ pathology
Neurodevelopmental Disorders
/ genetics
Epilepsy, Generalized
/ pathology
Movement Disorders
/ diagnostic imaging
Atrophy
/ pathology
Cataract
/ genetics
Phenotype
Mediator Complex
/ genetics
cerebellar atrophy
cerebello-lental degeneration
dystonia
gene transcription
mediator complex
neurodevelopmental disorders
Journal
Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537
Informations de publication
Date de publication:
01 12 2023
01 12 2023
Historique:
received:
27
01
2023
revised:
29
06
2023
accepted:
11
07
2023
medline:
4
12
2023
pubmed:
30
7
2023
entrez:
30
7
2023
Statut:
ppublish
Résumé
MED27 is a subunit of the Mediator multiprotein complex, which is involved in transcriptional regulation. Biallelic MED27 variants have recently been suggested to be responsible for an autosomal recessive neurodevelopmental disorder with spasticity, cataracts and cerebellar hypoplasia. We further delineate the clinical phenotype of MED27-related disease by characterizing the clinical and radiological features of 57 affected individuals from 30 unrelated families with biallelic MED27 variants. Using exome sequencing and extensive international genetic data sharing, 39 unpublished affected individuals from 18 independent families with biallelic missense variants in MED27 have been identified (29 females, mean age at last follow-up 17 ± 12.4 years, range 0.1-45). Follow-up and hitherto unreported clinical features were obtained from the published 12 families. Brain MRI scans from 34 cases were reviewed. MED27-related disease manifests as a broad phenotypic continuum ranging from developmental and epileptic-dyskinetic encephalopathy to variable neurodevelopmental disorder with movement abnormalities. It is characterized by mild to profound global developmental delay/intellectual disability (100%), bilateral cataracts (89%), infantile hypotonia (74%), microcephaly (62%), gait ataxia (63%), dystonia (61%), variably combined with epilepsy (50%), limb spasticity (51%), facial dysmorphism (38%) and death before reaching adulthood (16%). Brain MRI revealed cerebellar atrophy (100%), white matter volume loss (76.4%), pontine hypoplasia (47.2%) and basal ganglia atrophy with signal alterations (44.4%). Previously unreported 39 affected individuals had seven homozygous pathogenic missense MED27 variants, five of which were recurrent. An emerging genotype-phenotype correlation was observed. This study provides a comprehensive clinical-radiological description of MED27-related disease, establishes genotype-phenotype and clinical-radiological correlations and suggests a differential diagnosis with syndromes of cerebello-lental neurodegeneration and other subtypes of 'neuro-MEDopathies'.
Identifiants
pubmed: 37517035
pii: 7233760
doi: 10.1093/brain/awad257
pmc: PMC10690011
doi:
Substances chimiques
MED27 protein, human
0
Mediator Complex
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
5031-5043Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S01165X/1
Pays : United Kingdom
Organisme : NINDS NIH HHS
ID : R35 NS105078
Pays : United States
Organisme : Wellcome Trust
ID : WT093205MA
Pays : United Kingdom
Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of the Guarantors of Brain.
Références
Genet Med. 2022 Oct;24(10):2194-2203
pubmed: 36001086
Mov Disord. 2022 Oct;37(10):2139-2146
pubmed: 35876425
Cerebellum Ataxias. 2015 Jul 07;2:8
pubmed: 26331051
Eur J Med Genet. 2019 Feb;62(2):129-136
pubmed: 29959045
Pediatr Neurol. 2021 Oct;123:67-76
pubmed: 34399111
Bioinformatics. 2010 Mar 1;26(5):689-91
pubmed: 20061306
Mov Disord. 2020 Jun;35(6):994-1001
pubmed: 32181965
Eur J Pediatr. 2015 Jan;174(1):113-8
pubmed: 25446406
Clin Case Rep. 2019 Jan 09;7(2):331-335
pubmed: 30847200
Nature. 2017 Oct 11;550(7675):204-213
pubmed: 29022597
Cell. 2019 Aug 22;178(5):1145-1158.e20
pubmed: 31402173
Am J Med Genet A. 2020 Jul;182(7):1785-1790
pubmed: 32324310
Hum Mutat. 2015 Oct;36(10):928-30
pubmed: 26220891
Neurogenetics. 2018 May;19(2):93-103
pubmed: 29511999
Am J Med Genet A. 2021 Aug;185(8):2586-2592
pubmed: 33931951
Elife. 2016 Sep 26;5:
pubmed: 27669148
Autophagy. 2022 Mar;18(3):496-517
pubmed: 34130600
J Intellect Disabil Res. 2021 Dec;65(12):1049-1057
pubmed: 34713510
Genet Med. 2019 Dec;21(12):2713-2722
pubmed: 31155615
Bioinformatics. 2016 May 15;32(10):1454-61
pubmed: 26787668
Bioinformatics. 2020 May 1;36(10):3268-3270
pubmed: 32061125
Cerebellum. 2020 Aug;19(4):569-582
pubmed: 32410094
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Ann Neurol. 2021 Apr;89(4):828-833
pubmed: 33443317
Nat Rev Genet. 2010 Nov;11(11):761-72
pubmed: 20940737
J Chem Theory Comput. 2017 Jun 13;13(6):3031-3048
pubmed: 28430426
Am J Hum Genet. 2020 May 7;106(5):717-725
pubmed: 32330417
Hum Genet. 2015 Jun;134(6):577-87
pubmed: 25792360
Nat Rev Mol Cell Biol. 2015 Mar;16(3):155-66
pubmed: 25693131
Am J Hum Genet. 2010 Nov 12;87(5):667-70
pubmed: 20950787
Am J Hum Genet. 2019 Apr 4;104(4):709-720
pubmed: 30905399
Am J Med Genet A. 2021 Nov;185(11):3294-3313
pubmed: 34405553
Dev Med Child Neurol. 2020 Feb;62(2):178-191
pubmed: 31784983